Ascending to new heights for novel therapeutics for eosinophilic esophagitis

- Hirano, Ikuo, Dellon, Evan S., Peterson, Kathryn, Talley, Nicholas J., Bierdermann, Luc, von Arnim, Ulrike, Savarino, Edoardo V., Schlag, Christoph, Wershil, Barry K., Menard-Katcher, Calies, Muir, Amanda B., Wechsler, Joshua B., Falk, Gary W., Chehade, Mirna, Spergel, JM, Atkins, D, Oliva, S, Arva, NC, Guang-Yu, Y, Jensen, ET, Safroneeva, E, Ackerman, S, Gupta, SK, Gonsalves, Nirmala P., Rothenberg, M, Katzka, D, Pletneva, M, Wright, BL, Hiremath, G, Klion, A, Attwood, S, Bonis, P, Aceves, S, Ghisa, M, Furuta, Glenn T., Miehlke, S, Vanuytsel, T, Woodland, G, Thomas, G, Kuang, FL, Bredenoord, Albert J., Assessment of Clinical endpoints in Eosinophilic esophagitis for Novel Therapeutics (ASCENT) working group,, Straumann, Alex, Schoepfer, Alain, Chang, Joy W.

Impressions and aspirations from the FDA GREAT VI Workshop on Eosinophilic Gastrointestinal Disorders Beyond Eosinophilic Esophagitis and Perspectives for Progress in the Field

- Rothenberg, Marc E., Hottinger, Shawna K. B., Genta, Robert M., Chehade, Mirna, Gupta, Sandeep K., Spergel, Jonathan M., Aceves, Seema S., Dellon, Evan S., Gonsalves, Nirmala, Furuta, Glenn T., Collins, Margaret H., Talley, Nicholas J., Peterson, Kathryn, Menard-Katcher, Calies, Smith, Macie, Hirano, Ikuo